Not just a critique, an editorial that was published in the ADA's own flagship journal Diabetes Care. The experts included several past ADA Presidents and Award winners. Page views before the ADA publicized the editorial <300, approaching 10k now. Link below, let's help the ADA get the word out.

Brandon Friedman@brandonfriedman.bsky.social · 2mo ago

A real headline in the United States today

Thanks @resdevbcch.bsky.social, very grateful for support from @diabetescanada.bsky.social for our research on beta cell prohormone processing in #T1D. My first studentship was from @diabetescanada.bsky.social in 1988 and it's lovely to still be supported by them some ~37 years later!

BCCHR ResDev (DM)@resdevbcch.bsky.social · 7mo ago

🥳🥳 Many congratulations to funded diabetes researchers including @bruceverchere.bsky.social @nictitate.bsky.social & Shazhan Amed @bcchresearch.bsky.social

New publication @diabetologiajnl.bsky.social led by a fantastic former fellow on our team @hdenroche.bsky.social. Islet amyloid, long viewed as pathogenic for beta cells, surprisingly disrupts antigen presentation and delays autoimmune diabetes in NOD mice.

Diabetologia@diabetologiajnl.bsky.social · 7mo ago

While islet amyloid harms β cells in T2D, research reveals amyloid protects against β cell autoimmunity and diabetes in NOD mice by disrupting MHCII antigen presentation in islet macrophages link.springer.com/article/10.1... 🔓

CIRTN-R2FIC is currently running in Toronto its 4th Annual Meeting. During this meeting we have launched our mini interview series called "Islets in a Pod" ! Our first interview is with Dr. Patrick MacDonald from the University of Alberta. youtu.be/UlHn_1Fz3ck?...

#1 Islets in a Pod with Dr. Patrick MacDonald

YouTube video by CIRTN-R2FIC

youtu.be

www.canada.ca/en/institute... An inspired and excellent choice! Looking forward to great things under Mary's leadership.

🧵(1/12) November is Diabetes Awareness Month, and we have many works coming out from the CIRTN labs focusing on islet biology and diabetes. For the beginning of Nov 2025, we have papers from Drs Thompson, Verchere, Chen, Dhanvantari, Hill, Hoesli, Kin, Levings, Lynn, Riddell, Rutter and Wheeler.

Proud to play a small part in this terrific work from @thompsonisletlab.bsky.social Congrats Camille and Peter on a great paper. Proinsulin processing and senescence! @yichunchen.bsky.social @cirtn.bsky.social

Peter Thompson@thompsonisletlab.bsky.social · 9mo ago

🎉Very excited to share our new work on senescence and insulin processing now out in @DiabetologiaJnl link.springer.com/article/10.100… Fantastic effort by my @dream-diabetes.bsky.social trainees, along with @yichunchen.bsky.social @bruceverchere.bsky.social @cirtn.bsky.social

The interaction of GLP-1 medicines with the immune system is complex, enabled by direct and indirect actions, including neural inter organ communication. These studies have been led @SinaiHealth by CK Wong. His latest perspective here in the JCI www.jci.org/articles/vie...

A new study from Duke, led by Jonathan Campbell, PhD, reveals that pancreatic alpha cells do more than produce glucagon — they also generate GLP-1, a hormone that boosts insulin and regulates blood sugar. 🔗 Read more: https://medschool.duke.edu/news/alpha-cells-moonlight-secret-glp-1-factories

I recently had the opportunity to chat with Dr. Shazhan Amed about how she is using data in innovative ways to improve outcomes for children and youth living with type 1 diabetes. Thanks to the T2D Network (part of IHSTS) for hosting this conversation. www.youtube.com/watch?v=Eazx...

Empowering Diabetes Care Integrating Health Information

YouTube video by T2D Network

youtube.com

Novel insights into the molecular underpinnings of islet cell dysfunction in #T1D highlighting pathways that may be leveraged to preserve residual β-cell function and modulate α-cell activity @bcellorg.bsky.social www.jci.org/articles/vie...

The first GLP-1 medicine, twice daily exenatide was approved April 28 2005. Several decades later, the pace of innovation is expanding rapidly, encompassing new medicines and receptors, unique delivery options, and expanding therapeutic indications jamanetwork.com/journals/jam...

New Molecules and Indications for GLP-1 Medicines

This Perspective explores recent progress and future directions in glucagon-like peptide-1 medicines.

jamanetwork.com

Congratulations and thanks to both Sarah Cs @sarahcrome.bsky.social @sarahcolpitts.bsky.social for including us as part of this lovely study, showing a role or ILC2s in islet graft survival.

Sarah Crome@sarahcrome.bsky.social · last yr.

🧬 Excited to share our latest study now In Press: In this study led by rising star @sarahcolpitts.bsky.social, we show that IL-10⁺ #ILC2s prevent rejection and improve islet graft survival and function in humanized mouse models. Read more: doi.org/10.1016/j.aj... #Immunology #ImmunoSky #CellTherapy

How nice! Proud to be part of that group of colleagues and child health researchers. What a lovely recognition of recipients and reminder of Dr Hammond's leadership at @bcchresearch.bsky.social.

BCCHR ResDev (DM)@resdevbcch.bsky.social · last yr.

Fabulous new wall art @bcchresearch.bsky.social celebrating winners of GL Hammond Lectureship over past decade (1/y). 🎉🎉Congrats to all including @mklevings.bsky.social @wprobins.bsky.social @bruceverchere.bsky.social & others not on BSky.

New study on novel translation factor EIF2A led by Panzhinskiy as a collaboration between @jimjohnsonsci.bsky.social lab, Jan lab & @bruceverchere.bsky.social lab UBC Life Sciences Institute. Thanks Breakthrough T1D Canada for funding this project #DiabetesResearch link.springer.com/article/10.1...

Eukaryotic translation initiation factor 2A protects pancreatic beta cells during endoplasmic reticulum stress while rescuing global translation inhibition - Diabetologia

Aims/hypothesis The endoplasmic reticulum (ER) stress-induced unfolded protein response helps determine beta cell survival rate in diabetes. The alternative eukaryotic translation initiation factor 2A...

link.springer.com

Come join us at beautiful UBC! The King Lab is recruiting a Post-doc Fellow to develop mathematical theory on infectious disease evolution and emergence, together with Ben Ashby (SFU) #zoonoses #biodiversity www.zoology.ubc.ca/kinglab/join...

Join Us! | King Lab

Are you interested in joining the King Lab? More information here!

zoology.ubc.ca

We're looking for postdoctoral scholars to join our team in Vancouver 🇨🇦. We work on cell-based approaches aimed at curing type 1 diabetes. Bring your own ideas for projects or work on one that's already funded! More details here: www.nature.com/naturecareer...

Postdoctoral Research Fellow - Vancouver, British Columbia (CA) job with University of British Columbia Department of Surgery | 12837375

The successful candidate will work on a project developing cell-based therapies for those living with type 1 diabetes (T1D).

nature.com

Kicking off the ~15th annual A-BC Islet Workshop at beautiful Silver Star resort in BC. Great islet talks from trainees and keynotes @linnemannlab.bsky.social and @soleimanpourlab.bsky.social @ubcdiabetes.bsky.social

Fantastic opportunity for fellowship in an excellent T1D research training environment working in regenerative medicine and stem cells in the Breakthrough T1D Centre of Excellence at UBC. If you missed the NOI deadline, no worries, you can still apply! Reach out if you have any questions.

Stem Cell Network@stemcellnetwork.ca · last yr.

Are you applying for the J. Andrew McKee Fellowship in Type 1 Diabetes?    Supported by SCN and Breakthrough T1D (formerly JDRF), this is your chance to join UBC’s Breakthrough T1D Centre of Excellence. Submit your application by February 27, 2025. ➡️ stemcellnetwork.ca/training/exc...

This is the most relevant article to NIH and research cuts I’ve seen. Imagine if this was today , how many people would be saying “Why are we studying Gila Monsters and their impact on diabetes ? That’s wasted money !” globalnews.ca/news/9793403...

How a Canadian scientist and a venomous lizard helped pave the way for Ozempic - National | Globalnews.ca

In 1984, Dr. Daniel Drucker, an endocrinologist from the University of Toronto, discovered a hormone that helped pave the way for popular diabetes drugs such as Ozempic.

globalnews.ca

We have room and $ for postdoctoral fellows to join our team in beautiful Vancouver 🇨🇦. Get in touch if interested.

ubc.wd10.myworkdayjobs.com/en-US/ubcfac... We are looking for an imaging master to run a very cool shared microscope - Raman label-free, 2-photon, FLIM, high-res, fast capture, thick live tissue, organoids, high-content screening. We are a dynamic and supportive and fun environment.

Research Associate

Academic Job Category Faculty Non Bargaining Job Title Research Associate Department Johnson Laboratory | Department of Cellular and Physiological Sciences | Faculty of Medicine (James Johnson) Postin...

ubc.wd10.myworkdayjobs.com

🚀 Excited to announce that our Lab @UBC is recruiting! 🌟 We're looking for passionate intern, graduate, and postdoc with strong coding/ML backgrounds to join us in advancing AI for single-cell biology & brain-computer interfaces. 🏔️ Vancouver awaits! 👉 tanglab.msl.ubc.ca 📧 xin.tang@msl.ubc.ca

Thrilled to share one of our biggest discoveries: “Inceptor binds to and directs insulin towards lysosomal degradation in beta cells”. doi.org/10.1038/s422... A tremendous collaborative effort led by JohannaSiehler, Sara Bilekova and other members of the Lickert lab @heikolickert.bsky.social

Inceptor binds to and directs insulin towards lysosomal degradation in β cells - Nature Metabolism

The insulin inhibitory receptor (inceptor) is found to bind to insulin and to regulate insulin stores by directing proinsulin and insulin towards lysosomal degradation.

doi.org

Great to have this paper out in diabetesjournals.org/diabetes! Appreciate the feedback from reviewers and funding from BreakthroughT1D that made this work possible. pubmed.ncbi.nlm.nih.gov/39561351/

And in an effort to build community (after I saw the Swiss starter pack! ) - here's one for scientists in Canada! Let me know who I missed. go.bsky.app/4owyF32

@nictitate.bsky.social deservedly recognized for his outstanding mentorship at the 3rd Canadian Islet Research Training Network meeting in Halifax

@bruinjenny1.bsky.social kicking off the 3rd annual Canadian Islet Research Training Network (CIRTN) meeting in Halifax by thanking sponsors, including our BC Diabetes Research Network and Canucks for Kids Fund Childhood Diabetes Labs at BC Children's Hospital! Two days of trainee led islet biology!

Who doesn’t love talking #islet biology??!!!

Keynote speaker Dr. Anna Gloyn kicking off our 11th Annual Vancouver Diabetes Research Day (VDRD) on Nov 14, World Diabetes Day, supported by the BC Diabetes Research Network